Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Go back to Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
(NASDAQ: IOVA) Delayed: 8.79 +0.09 (1.03%)
Previous Close $8.70    52 Week High
Open $8.74    52 Week Low
Day High $8.90    P/E N/A 
Day Low $8.64    EPS
Volume 8,079,599